Edward M. Rudnic, President and CEO at MiddleBrook Pharmaceuticals, Inc. (MBRK), sold 27,000 shares at $2.37 ($63K) on 2007-08-23, disclosed to the SEC on 2007-08-24.
Scheduled sale ($63k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 700 | $2K | 2.5% |
| 2 | $2.31 | 2,858 | $7K | 10.4% |
| 3 | $2.32 | 4,021 | $9K | 14.7% |
| 4 | $2.33 | 200 | $466 | 0.7% |
| 5 | $2.34 | 800 | $2K | 3.0% |
| 6 | $2.35 | 1,200 |
| $3K |
| 4.5% |
| 7 | $2.39 | 21 | $50 | 0.1% |
| 8 | $2.40 | 5,600 | $13K | 21.2% |
| 9 | $2.42 | 100 | $242 | 0.4% |
| 10 | $2.43 | 400 | $972 | 1.5% |
| 11 | $2.49 | 100 | $249 | 0.4% |
| 12 | $2.30 | 1,000 | $2K | 3.6% |
| 13 | $2.31 | 4,300 | $10K | 15.7% |
| 14 | $2.32 | 1,329 | $3K | 4.9% |
| 15 | $2.33 | 1,200 | $3K | 4.4% |
| 16 | $2.34 | 600 | $1K | 2.2% |
| 17 | $2.35 | 100 | $235 | 0.4% |
| 18 | $2.36 | 300 | $708 | 1.1% |
| 19 | $2.37 | 500 | $1K | 1.9% |
| 20 | $2.40 | 471 | $1K | 1.8% |
| 21 | $2.41 | 200 | $482 | 0.8% |
| 22 | $2.45 | 1,000 | $2K | 3.9% |
| Total | $2.35 avg | 27,000 | $63K | 100% |
| Filing → |
| MBRK | SELL | 2007-11-23 | $20K | — | Filing → |
| MBRK | SELL | 2007-10-18 | $18K | — | Filing → |
| MBRK | SELL | 2007-10-17 | $42K | — | Filing → |